Following a barrage of letters from President Donald Trump urging 17 large pharmaceutical companies to implement Most Favored ...

The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to ...

Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...

It’s a bad time to try to predict future pharmaceutical prices.

US President Donald Trump recently announced tariffs as high as 100% on certain semiconductor products. Although South Korea ...

Trump’s MFN price controls on drugs will harm U.S. companies and patients.

Nepali mixed martial artist Ravindra Dhat has captured national and international attention after he won the bantamweight ...

President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to ...

The Trump Administration is pursuing decidedly anti-growth policies. The results will be a weaker economy that violates his ...

Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...

The MFN Executive Order is a bold attempt to recalibrate global drug pricing — with U.S. patients at the center. But without clear enforcement, legal grounding, or international cooperation, its ...